Wen David, Collantes Elena, Sgromo Bruno
University of Oxford Medical School, John Radcliffe Hospital, Oxford, UK.
Department of Cellular Pathology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Clin J Gastroenterol. 2018 Dec;11(6):470-475. doi: 10.1007/s12328-018-0890-0. Epub 2018 Aug 25.
A 62-year-old female patient diagnosed with oesophageal adenocarcinoma underwent radical treatment consisting of neoadjuvant chemotherapy and oesophagectomy with no major complications. Eleven months later, she re-presented with a mass at one of the chest drain sites. A PET-CT scan and biopsy demonstrated this to be a single recurrence of the oesophageal adenocarcinoma. Excision of the metastatic lesion was considered as per metachronous single site metastasis. However, the operation was postponed due to acute kidney injury. Restaging after 6 weeks revealed progressive metastatic disease. The patient underwent palliative therapy and passed away soon after. Oesophageal cancer recurrence has a very poor prognosis, and factors such as the disease-free interval, site of recurrence and tumour pathological factors must be considered when stratifying for suitability for metastasectomy. A period of watchful waiting followed by restaging is essential to rule out patients with indolent metastatic disease.
一名62岁的女性患者被诊断为食管腺癌,接受了包括新辅助化疗和食管切除术在内的根治性治疗,未出现重大并发症。11个月后,她因胸部引流部位之一出现肿块而再次就诊。PET-CT扫描和活检显示这是食管腺癌的单一复发。根据异时性单部位转移情况,考虑切除转移性病变。然而,由于急性肾损伤,手术被推迟。6周后的重新分期显示转移性疾病进展。患者接受了姑息治疗,不久后去世。食管癌复发的预后非常差,在对是否适合进行转移灶切除术进行分层时,必须考虑无病间期、复发部位和肿瘤病理因素等。一段观察等待期后进行重新分期对于排除惰性转移性疾病患者至关重要。